Cow Milk Fat Obesity pRevention Trial (CoMFORT)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jonathon L Maguire, MD, FRCPC
- Phone Number: (416) 867-3655
- Email: jonathon.maguire@utoronto.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B 1W8
- Recruiting
- St. Michael's Hospital
-
Contact:
- Jonathon L Maguire, MD, FRCPC
- Phone Number: (416) 867-3655
- Email: jonathon.maguire@utoronto.ca
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- healthy by parental report;
- 1.5 to 2.99 years of age
- involved in a TARGet Kids! academic pediatric or family medicine group.
Exclusion Criteria:
- Prader-Willi syndrome or other syndrome associated with obesity
- severe development delay
- children who are from families without verbal communication in English or French
- failure to thrive (with zBMI values ≤ -2 are unlikely to benefit from obesity prevention)
- siblings of trial participants as families may share milk
- will not consume cow's milk by choice, lactose intolerance or allergy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Whole (3.25%) milk
|
Children randomized to the whole milk recommendation will receive a recommendation a primary care recommendation to consume 500 mL of whole fat (3.25%) milk instead of transitioning to reduced fat (1%) milk at 2 years of age.
The primary care physician will verbally make this recommendation during the recruitment well-child visit.
Parents will also be reminded bi-monthly by phone calls made by a research assistant.
Children in the whole milk recommendation group will be provided with the same age-appropriate nutritional recommendations as children in the reduced fat recommendation group as part of routine healthcare according to the Rourke Baby Record.
|
|
Active Comparator: Reduced fat (1%) milk
|
Children randomized to the reduced fat group will receive a primary care recommendation to transition from whole milk to 500 mL reduced fat (1%) milk daily once the child is two years of age (consistent with current guidelines).
The physician will verbally make this recommendation during the recruitment well-child visit.
Parents will also be reminded bi-monthly by phone calls made by a research assistant.
Children who receive the reduced fat recommendation will be provided with the same age-appropriate nutritional recommendations as children who receive the whole fat recommendation as part of routine healthcare according to the Rourke Baby Record.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
weight
Time Frame: Measured 24 months post-study entry
|
kilograms; measured using a Healthometer stadiometer
|
Measured 24 months post-study entry
|
|
height
Time Frame: Measured 24 months post-study entry
|
metres; measured using a Healthometer statiometer
|
Measured 24 months post-study entry
|
|
body mass index z-score (zBMI)
Time Frame: Measured 24 months post-study entry
|
BMI calculated by weight (kg)/height (m^2); zBMI determined according to the World Health Organization guidelines
|
Measured 24 months post-study entry
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
serum 25-hydroxyvitamin D
Time Frame: Measured 24 months post-study entry
|
measured in nmol/L
|
Measured 24 months post-study entry
|
|
serum glucose
Time Frame: measured 24 months post-study entry
|
measured in mmol/L
|
measured 24 months post-study entry
|
|
blood pressure
Time Frame: measured 24 months post-study entry
|
systolic and diastolic
|
measured 24 months post-study entry
|
|
serum insulin
Time Frame: measured 24 months post-study entry
|
measured in mmol/L
|
measured 24 months post-study entry
|
|
serum triglycerides
Time Frame: measured 24 months post-study entry
|
measured in mmol/L
|
measured 24 months post-study entry
|
|
serum total cholesterol
Time Frame: measured 24 months post-study entry
|
measured in mmol/L
|
measured 24 months post-study entry
|
|
serum high density lipoprotein cholesterol
Time Frame: measured 24 months post-study entry
|
measured in mmol/L
|
measured 24 months post-study entry
|
|
serum low density lipoprotein cholesterol
Time Frame: measured 24 months post-study entry
|
measured in mmol/L
|
measured 24 months post-study entry
|
|
serum non-high density lipoprotein cholesterol
Time Frame: measured 24 months post-study entry
|
measured in mmol/L
|
measured 24 months post-study entry
|
|
serum highly sensitive c-reactive protein
Time Frame: measured 24 months post-study entry
|
measured in mg/L
|
measured 24 months post-study entry
|
|
height z-score
Time Frame: measured 24 months post-study entry
|
measured by a trained research assistant according to the World Health Organization guidelines
|
measured 24 months post-study entry
|
|
waist circumference
Time Frame: measured 24 months post-study entry
|
measured by a trained research assistant
|
measured 24 months post-study entry
|
|
lean body mass
Time Frame: measured 24 months post-study entry
|
measured in kg, % body weight
|
measured 24 months post-study entry
|
|
fat mass
Time Frame: measured 24 months post-study entry
|
measured in kg, % body weight
|
measured 24 months post-study entry
|
|
school readiness
Time Frame: measured 24 months post-study entry
|
measured using the Early Development Instrument (EDI); children scoring at or below the 25th percentile of children in their province are considered at risk for continuing on the low achievement and health trajectory, and are more likely to fall behind in academic achievement in later grades
|
measured 24 months post-study entry
|
|
cognitive development
Time Frame: measured 24 months post-study entry
|
measured using the Ages and Stages Questionnaire (ASQ)
|
measured 24 months post-study entry
|
|
dietary intake
Time Frame: measured 24 months post-study entry
|
measured using the Automated Multiple Pass Self Administered 24 hour recall (ASA24) tool
|
measured 24 months post-study entry
|
|
carotid intima media thickness (cIMT)
Time Frame: measured 24 months post-study entry
|
measured by ultrasound
|
measured 24 months post-study entry
|
|
restrained and emotional eating
Time Frame: measured 24 months post-study entry
|
measured using the 3-factor eating questionnaire
|
measured 24 months post-study entry
|
|
nutritional risk
Time Frame: measured 24 months post-study entry
|
measured using NutriSTEP preschooler
|
measured 24 months post-study entry
|
|
physical activity (minutes per day)
Time Frame: measured 24 months post-study entry
|
questionnaire data and accelerometry
|
measured 24 months post-study entry
|
|
sleep time (hours per night)
Time Frame: measured 24 months post-study entry
|
questionnaire data and accelerometry
|
measured 24 months post-study entry
|
|
healthcare service utilization
Time Frame: measured 24 months post-study entry
|
information accessed through OHIP linkage
|
measured 24 months post-study entry
|
|
upper respiratory tract infection incidence
Time Frame: measured 24 months post-study entry
|
information accessed through OHIP linkage
|
measured 24 months post-study entry
|
|
growth trajectories
Time Frame: measured 24 months post-study entry
|
zBMI growth rates
|
measured 24 months post-study entry
|
|
head circumference
Time Frame: measured 24 months post-study entry
|
measured by a trained research assistant
|
measured 24 months post-study entry
|
|
cost effectiveness
Time Frame: measured 24 months post-study entry
|
All costs, parameter estimates and ranges will be derived from study data and will be obtained using medical record extraction.
Publicly available Ontario costing sources will be used to cost resource utilisation parameters.
|
measured 24 months post-study entry
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Jonathon L Maguire, MD, FRCPC, Unity Health Toronto
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 18-369
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.